(Q41057213)

26 September 2017

title

Inflammatory Markers Related to Microbial Translocation Among HIV-Infected Pregnant Women: A Risk Factor of Preterm Delivery (English)

1 reference

26 September 2017

0 references

1 reference

9

1 reference

26 September 2017

Jordi Vila

7

0 references

author name string

Marta López

1

1 reference

26 September 2017

Francesc Figueras

2

1 reference

26 September 2017

Oriol Coll

3

1 reference

26 September 2017

Anna Goncé

4

1 reference

26 September 2017

Sandra Hernández

5

1 reference

26 September 2017

Montse Loncá

6

1 reference

26 September 2017

Eduard Gratacós

8

1 reference

26 September 2017

language of work or name

English

0 references

publication date

11 August 2015

1 reference

Journal of Infectious Diseases

26 September 2017

published in

1 reference

26 September 2017

volume

213

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

343-350

1 reference

Preterm birth aetiology 2004-2008. Maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Economic consequences of preterm birth and low birthweight

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Combination antiretroviral use and preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Infection and Preterm Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

The preterm parturition syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Epidemiology and causes of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Microbial translocation in HIV infection: causes, consequences and treatment opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

HIV disease: fallout from a mucosal catastrophe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Placental transfer of IgG and IgG subclass antibodies anti-purified Escherichia coli LPS O16, O6 and O111.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Placental pathology: a systematic approach with clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Lipopolysaccharide-binding protein in microbial invasion of the amniotic cavity and human parturition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

The placenta harbors a unique microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

The microbiome, parturition, and timing of birth: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

Evidence of participation of soluble CD14 in the host response to microbial invasion of the amniotic cavity and intra-amniotic inflammation in term and preterm gestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV416

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV416

1 reference

26 September 2017

1 reference